Philip Morris International Appoints Business Accelerator Dessi Temperley to its Board of Directors
10 Dezembro 2021 - 8:30AM
Business Wire
Philip Morris International Inc. (PMI) (NYSE: PM) today
announced that on December 6, 2021, its Board of Directors
appointed a new member, Ms. Dessislava (“Dessi”) Temperley.
Dessi Temperley is a former global public company CFO with more
than 25 years of experience across a variety of sectors, working
for several blue-chip multinationals. She has a proven track record
of delivering strategic change with strong operational leadership
resulting in superior financial results, most recently as Group CFO
and Executive Board Member of Beiersdorf AG. Prior to this, she
held several senior positions at Nestlé. She is also a
non-executive member of the Board of Directors for Coca-Cola
Europacific Partners, Corbion and Cimpress.
André Calantzopoulos, PMI Executive Chairman, commended
Temperley on the appointment, and said, “We are pleased to have
Dessi Temperley join the Philip Morris International Board of
Directors. She brings extensive experience with financial planning
and strategy, M&A and reporting to drive our business
performance, and help navigate the increasing pace and scale of
PMI’s continued evolution toward delivering a smoke-free future and
beyond.”
Philip Morris International: Delivering a Smoke-Free
Future
Philip Morris International (PMI) is leading a transformation in
the tobacco industry to create a smoke-free future and ultimately
replace cigarettes with smoke-free products to the benefit of
adults who would otherwise continue to smoke, society, the company,
its shareholders and other stakeholders. PMI is a leading
international tobacco company engaged in the manufacture and sale
of cigarettes, as well as smoke-free products, associated
electronic devices and accessories, and other nicotine-containing
products in markets outside the U.S. In addition, versions of PMI's
IQOS Platform 1 device and consumables have received marketing
authorizations from the U.S. Food and Drug Administration (FDA)
under the premarket tobacco product application (PMTA) pathway; the
FDA has also authorized the marketing of a version of IQOS and its
consumables as a Modified Risk Tobacco Product (MRTP), finding that
an exposure modification order for these products is appropriate to
promote the public health. PMI is building a future on a new
category of smoke-free products that, while not risk-free, are a
much better choice than continuing to smoke. Through
multidisciplinary capabilities in product development,
state-of-the-art facilities and scientific substantiation, PMI aims
to ensure that its smoke-free products meet adult consumer
preferences and rigorous regulatory requirements. PMI's smoke-free
product portfolio includes heat-not-burn products,
nicotine-containing vapor products and oral nicotine products. As
of September 30, 2021, PMI's smoke-free products are available for
sale in 70 markets in key cities or nationwide, and PMI estimates
that approximately 14.9 million adults around the world have
already switched to IQOS and stopped smoking. For more information,
please visit www.pmi.com and www.pmiscience.com.
# # #
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211210005136/en/
Philip Morris International David Fraser / Corey Henry T. +41 79
843 8603 / +1 (202) 679 7296 E. David.Fraser@pmi.com /
Corey.Henry@pmi.com
Philip Morris (NYSE:PM)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Philip Morris (NYSE:PM)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024